What is the NanoenTek Inc. stock price forecast?

NanoenTek Inc. is currently trading at ₩7,350. View real-time AI analysis on Alpha Lenz.

What is NanoenTek Inc. insider trading activity?

View the latest insider trading data for NanoenTek Inc. on Alpha Lenz.

What is NanoenTek Inc.'s P/E ratio?

NanoenTek Inc.'s P/E ratio is 61.6.

NanoenTek Inc.

KRX · 039860

₩7,350

Ask about NanoenTek Inc.'s future dividend policy...

Alpha Chat Insight

“NanoenTek Inc. trades at a P/E of 61.6 (premium valuation) with modest ROE of 5.6%.”

Ask for details →

Company Overview

NanoenTek Inc. is a pioneering biotechnology company specializing in the development and manufacturing of cutting-edge diagnostic and research tools. With a focus on innovative lab-on-a-chip technologies, NanoenTek delivers solutions designed to enhance the efficiency and accuracy of laboratory tests and research applications. The company's product line primarily serves the healthcare and research sectors, providing essential equipment for point-of-care diagnostics and cellular research, thereby impacting hospitals, laboratories, and research institutions globally. NanoenTek is known for its commitment to advancing technology that supports rapid and reliable diagnostics, thus playing a significant role in the biotechnology and life sciences industries. Its contributions are crucial in settings where precision and expedited results are paramount, reinforcing its presence and importance in the global diagnostics market.

CEO정찬일

Websitehttps://www.nanoentek.com

SectorTechnology

IndustryScientific & Technical Instruments

Employees140

Company Statistics

FY 2024

Profile

₩279,983,939,550Market Cap

₩30,464,019,320Revenue

38.09MShares Out

140Employees

Margins

55.92%Gross

20.97%EBITDA

2.04%Operating

12.20%Pre-Tax

11.77%Net

Valuation

61.62P/E

2.99P/B

7.25EV/Sales

33.78EV/EBITDA

-46.69P/FCF

Growth (CAGR)

-5.22%Rev 3Yr

3.02%Rev 5Yr

-50.87%Op Inc 3Yr

-27.27%Op Inc 5Yr

-21.17%Net Inc 3Yr

-9.01%Net Inc 5Yr

Returns

5.21%ROA

5.62%ROE

5.42%ROIC

Financial Health

₩5,628,621,920Cash & Cash Equivalents

₩-616,571,570Net Debt

6.77%Debt/Equity

N/AInterest Cov